Luteal Phase Epigenetic Biomarkers Identify Premenstrual Dysphoric Disorder (PMDD) and Selective Serotonin Reuptake Response in PMDD

被引：0

作者：

Kaminsky, Zachary ^{[1
]}

Hantsoo, Liisa ^{[2
]}

Payne, Jennifer ^{[3
]}

机构：

[1] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada

[2] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA

[3] Univ Virginia, Charlottesville, VA 22903 USA

来源：

BIOLOGICAL PSYCHIATRY | 2023年 / 93卷 / 09期

关键词：

Epigenetic biomarkers; Premenstrual dysphoric disorder; SSRI response; Reproductive depression;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：S135 / S136

页数：2

共 50 条

[21] Evaluation of Premenstrual Dysphoric Disorder (PMDD) using daily diary and results of a prospective clinical study on the efficacy of selective serotonin reuptake inhibitor, fluvoxamine
Ushiroyama, T
Kiuchi, C
Koumura, H
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2005, 58 (06) : S45 - S45
[22] PMDD (premenstrual dysphoric disorder) - a challenge for both gynaecologists and psychiatrists
Andersen, B
NORDIC JOURNAL OF PSYCHIATRY, 2000, 54 : 8 - 8
[23] Fluoxetine treatment of premenstrual dysphoric disorder (PMDD) in adolescents.
Silber, TJ
Valadez-Meltzer, A
JOURNAL OF ADOLESCENT HEALTH, 2002, 30 (02) : 126 - 126
[24] SYMPTOMS AND IMPACT OF PREMENSTRUAL DYSPHORIC DISORDER (PMDD): CONCEPTS AND MEASUREMENT
Rofail, D.
Abetz, L.
Lindemann, M.
Filonenko, A.
Colligs, A.
Endicott, J.
VALUE IN HEALTH, 2009, 12 (07) : A295 - A296
[25] Premenstrual dysphoric disorder (PMDD) and work efficiency: Response to fluoxetine in a randomized clinical trial
Steiner, M
Trzepacz, P
Brown, E
Dillon, J
BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 116S - 117S
[26] Premenstrual dysphoric disorder (PMDD) and work efficiency: Response to fluoxetine in a randomized clinical trial
Trzepacz, PT
Steiner, M
Brown, E
PSYCHOSOMATICS, 2001, 42 (02) : 184 - 185
[27] The premenstrual syndromes PMD and PMDD: Premenstrual dysphoric disorder—myth or disorder in need of treatment?
Dorsch V.
Der Gynäkologe, 2018, 51 (2): : 110 - 116
[28] The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Halbreich, U
Borenstein, J
Pearlstein, T
Kahn, LS
PSYCHONEUROENDOCRINOLOGY, 2003, 28 : 1 - 23
[29] Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
Jespersen, Cecilie
Lauritsen, Mette Petri
Frokjaer, Vibe G.
Schroll, Jeppe B.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (08):
[30] Exploring premenstrual dysphoric disorder (PMDD) in the work context: a qualitative study
Hardy, Claire
Hardie, Jenna
JOURNAL OF PSYCHOSOMATIC OBSTETRICS & GYNECOLOGY, 2017, 38 (04) : 292 - 300

← 1 2 3 4 5 →